These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 26502714)

  • 1. Temporal changes in haematocrit following artemisinin-based combination treatments of uncomplicated falciparum malaria in children.
    Sowunmi A; Akano K; Ayede AI; Ntadom G; Fatunmbi B; Aderoyeje T; Adewoye EO
    BMC Infect Dis; 2015 Oct; 15():454. PubMed ID: 26502714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic efficacy and effects of artesunate-amodiaquine and artemether-lumefantrine on malaria-associated anaemia in Nigerian children aged two years and under.
    Sowunmi A; Akano K; Ayede AI; Ntadom G; Adewoye EO; Fatunmbi B; Aderoyeje T
    Infect Dis Poverty; 2016 Jul; 5(1):70. PubMed ID: 27384596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic efficacy and effects of artemisinin-based combination treatments on uncomplicated Plasmodium falciparum malaria -associated anaemia in Nigerian children during seven years of adoption as first-line treatments.
    Sowunmi A; Akano K; Ntadom G; Ayede AI; Ibironke FO; Aderoyeje T; Adewoye EO; Fatunmbi B; Oguche S; Okafor HU; Watila I; Meremikwu M; Agomo P; Ogala W; Agomo C; Folarin OA; Gbotosho GO; Happi CT
    Infect Dis Poverty; 2017 Feb; 6(1):36. PubMed ID: 28173853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical illness and outcomes in Nigerian children with late-appearing anaemia after artemisinin-based combination treatments of uncomplicated falciparum malaria.
    Sowunmi A; Akano K; Ayede AI; Ntadom G; Aderoyeje T; Adewoye EO; Fatunmbi B
    BMC Infect Dis; 2016 Jun; 16():240. PubMed ID: 27246468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors contributing to anaemia after uncomplicated falciparum malaria in under five year-old Nigerian children ten years following adoption of artemisinin-based combination therapies as first-line antimalarials.
    Sowunmi A; Fatunmbi B; Akano K; Wewe OA; Agomo C; Finomo F; Ebenebe J; Jiya N; Ambe J; Wammanda R; Ntadom G; Mokuolu O; Emechebe G; Ezeigwe N; Ayede AI; Adewoye EO; Gbotosho GO; Folarin OA; Happi CT; Oguche S; Oyibo WA; Useh F
    BMC Infect Dis; 2017 Dec; 17(1):781. PubMed ID: 29258448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anaemia following Artemisinin-Based Combination Treatments of Uncomplicated Plasmodium falciparum Malaria in Children: Temporal Patterns of Haematocrit and the Use of Uncomplicated Hyperparasitaemia as a Model for Evaluating Late-Appearing Anaemia.
    Sowunmi A; Akano K; Ntadom G; Ayede A; Oguche S; Agomo C; Okafor H; Watila I; Meremikwu M; Ogala W; Agomo P; Adowoye E; Fatunmbi B; Aderoyeje T; Happi C; Gbotosho G; Folarin O
    Chemotherapy; 2017; 62(4):231-238. PubMed ID: 28448988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical illness and outcomes in Nigerian children with persistent early-appearing anaemia following initiation of artemisinin-based combination treatments of uncomplicated falciparum malaria.
    Akano K; Fatunmbi B; Ntadom G; Ayede AI; Aderoyeje T; Bakre A; Alebiosu OT; Akpoborie O; Okafor C; Gbotosho GO; Folarin OA; Ebenebe JC; Ambe J; Wammanda R; Jiya N; Finomo F; Emechebe G; Mokuolu O; Agomo C; Oguche S; Happi C; Sowunmi A
    Parasite; 2019; 26():56. PubMed ID: 31516119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Declining responsiveness of childhood Plasmodium falciparum infections to artemisinin-based combination treatments ten years following deployment as first-line antimalarials in Nigeria.
    Sowunmi A; Ntadom G; Akano K; Ibironke FO; Ayede AI; Agomo C; Folarin OA; Gbotosho GO; Happi C; Oguche S; Okafor HU; Meremikwu M; Agomo P; Ogala W; Watila I; Mokuolu O; Finomo F; Ebenebe JC; Jiya N; Ambe J; Wammanda R; Emechebe G; Oyibo W; Useh F; Aderoyeje T; Dokunmu TM; Alebiosu OT; Amoo S; Basorun OK; Wewe OA; Okafor C; Akpoborie O; Fatunmbi B; Adewoye EO; Ezeigwe NM; Oduola A
    Infect Dis Poverty; 2019 Aug; 8(1):69. PubMed ID: 31383040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early rising asexual parasitaemia in Nigerian children following a first dose of artemisinin-based combination treatments of falciparum malaria.
    Sowunmi A; Akano K; Ayede AI; Adewoye EO; Ntadom G; Fatunmbi B; Gbotosho GO; Folarin OA; Happi CT
    BMC Infect Dis; 2017 Jan; 17(1):110. PubMed ID: 28143417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral artesunate-amodiaquine and artemether-lumefantrine in the treatment of uncomplicated hyperparasitaemic Plasmodium falciparum malaria in children.
    Gbotosho GO; Sowunmi A; Okuboyejo TM; Happi CT
    J Trop Pediatr; 2012 Apr; 58(2):151-3. PubMed ID: 21622538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pyronaridine-artesunate or dihydroartemisinin-piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial.
    West African Network for Clinical Trials of Antimalarial Drugs (WANECAM)
    Lancet; 2018 Apr; 391(10128):1378-1390. PubMed ID: 29606364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo/ex vivo efficacy of artemether-lumefantrine and artesunate-amodiaquine as first-line treatment for uncomplicated falciparum malaria in children: an open label randomized controlled trial in Burkina Faso.
    Lingani M; Bonkian LN; Yerbanga I; Kazienga A; Valéa I; Sorgho H; Ouédraogo JB; Mens PF; Schallig HDFH; Ravinetto R; d'Alessandro U; Tinto H
    Malar J; 2020 Jan; 19(1):8. PubMed ID: 31906948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized trial of artesunate-amodiaquine versus artemether-lumefantrine in Ghanaian paediatric sickle cell and non-sickle cell disease patients with acute uncomplicated malaria.
    Adjei GO; Goka BQ; Enweronu-Laryea CC; Rodrigues OP; Renner L; Sulley AM; Alifrangis M; Khalil I; Kurtzhals JA
    Malar J; 2014 Sep; 13():369. PubMed ID: 25236838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repeated treatment of recurrent uncomplicated Plasmodium falciparum malaria in Senegal with fixed-dose artesunate plus amodiaquine versus fixed-dose artemether plus lumefantrine: a randomized, open-label trial.
    Ndiaye JL; Faye B; Gueye A; Tine R; Ndiaye D; Tchania C; Ndiaye I; Barry A; Cissé B; Lameyre V; Gaye O
    Malar J; 2011 Aug; 10():237. PubMed ID: 21838909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early parasite clearance following artemisinin-based combination therapy among Ugandan children with uncomplicated Plasmodium falciparum malaria.
    Muhindo MK; Kakuru A; Jagannathan P; Talisuna A; Osilo E; Orukan F; Arinaitwe E; Tappero JW; Kaharuza F; Kamya MR; Dorsey G
    Malar J; 2014 Jan; 13():32. PubMed ID: 24468007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of artesunate-mefloquine and artemether-lumefantrine fixed-dose combinations for treatment of uncomplicated Plasmodium falciparum malaria in children younger than 5 years in sub-Saharan Africa: a randomised, multicentre, phase 4 trial.
    Sirima SB; Ogutu B; Lusingu JPA; Mtoro A; Mrango Z; Ouedraogo A; Yaro JB; Onyango KO; Gesase S; Mnkande E; Ngocho JS; Ackermann I; Aubin F; Vanraes J; Strub N; Carn G
    Lancet Infect Dis; 2016 Oct; 16(10):1123-1133. PubMed ID: 27430374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Artesunate + amodiaquine versus artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in the Colombian Pacific region: a noninferiority trial.
    De la Hoz Restrepo F; Porras Ramírez A; Rico Mendoza A; Córdoba F; Rojas DP
    Rev Soc Bras Med Trop; 2012 Dec; 45(6):732-8. PubMed ID: 23295878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of artesunate-amodiaquine vs. artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in Nanoro, Burkina Faso: a non-inferiority randomised trial.
    Tinto H; Diallo S; Zongo I; Guiraud I; Valea I; Kazienga A; Kpoda H; Sorgho H; Ouédraogo JB; Guiguemdé TR; D'Alessandro U
    Trop Med Int Health; 2014 Apr; 19(4):469-75. PubMed ID: 24494602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amodiaquine and artemether-lumefantrine select distinct alleles of the Plasmodium falciparum mdr1 gene in Tanzanian children treated for uncomplicated malaria.
    Humphreys GS; Merinopoulos I; Ahmed J; Whitty CJ; Mutabingwa TK; Sutherland CJ; Hallett RL
    Antimicrob Agents Chemother; 2007 Mar; 51(3):991-7. PubMed ID: 17194834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Open-label, randomized, non-inferiority clinical trial of artesunate-amodiaquine versus artemether-lumefantrine fixed-dose combinations in children and adults with uncomplicated falciparum malaria in Côte d'Ivoire.
    Toure OA; Assi SB; N'Guessan TL; Adji GE; Ako AB; Brou MJ; Ehouman MF; Gnamien LA; Coulibaly MA; Coulibaly B; Beourou S; Bassinka I; Soumahoro A; Kadjo F; Tano MA
    Malar J; 2014 Nov; 13():439. PubMed ID: 25409546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.